319 related articles for article (PubMed ID: 30616239)
21. The NSD1 and EZH2 overgrowth genes, similarities and differences.
Tatton-Brown K; Rahman N
Am J Med Genet C Semin Med Genet; 2013 May; 163C(2):86-91. PubMed ID: 23592277
[TBL] [Abstract][Full Text] [Related]
22. Reprogramming of the Epigenome by MLL1 Links Early-Life Environmental Exposures to Prostate Cancer Risk.
Wang Q; Trevino LS; Wong RL; Medvedovic M; Chen J; Ho SM; Shen J; Foulds CE; Coarfa C; O'Malley BW; Shilatifard A; Walker CL
Mol Endocrinol; 2016 Aug; 30(8):856-71. PubMed ID: 27219490
[TBL] [Abstract][Full Text] [Related]
23. The Kdm/Kmt gene families in the self-fertilizing mangrove rivulus fish, Kryptolebias marmoratus, suggest involvement of histone methylation machinery in development and reproduction.
Fellous A; Earley RL; Silvestre F
Gene; 2019 Mar; 687():173-187. PubMed ID: 30458291
[TBL] [Abstract][Full Text] [Related]
24. Wedelolactone Targets EZH2-mediated Histone H3K27 Methylation in Mantle Cell Lymphoma.
Romanchikova N; Trapencieris P
Anticancer Res; 2019 Aug; 39(8):4179-4184. PubMed ID: 31366503
[TBL] [Abstract][Full Text] [Related]
25. The NSD family of protein methyltransferases in human cancer.
Vougiouklakis T; Hamamoto R; Nakamura Y; Saloura V
Epigenomics; 2015 Aug; 7(5):863-74. PubMed ID: 25942451
[TBL] [Abstract][Full Text] [Related]
26. Deregulated expression of selected histone methylases and demethylases in prostate carcinoma.
Vieira FQ; Costa-Pinheiro P; Ramalho-Carvalho J; Pereira A; Menezes FD; Antunes L; Carneiro I; Oliveira J; Henrique R; Jerónimo C
Endocr Relat Cancer; 2014 Feb; 21(1):51-61. PubMed ID: 24200674
[TBL] [Abstract][Full Text] [Related]
27. Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy.
Katoh M
Epigenomics; 2016 Feb; 8(2):285-305. PubMed ID: 26411517
[TBL] [Abstract][Full Text] [Related]
28. Transcription factor Ap2delta associates with Ash2l and ALR, a trithorax family histone methyltransferase, to activate Hoxc8 transcription.
Tan CC; Sindhu KV; Li S; Nishio H; Stoller JZ; Oishi K; Puttreddy S; Lee TJ; Epstein JA; Walsh MJ; Gelb BD
Proc Natl Acad Sci U S A; 2008 May; 105(21):7472-7. PubMed ID: 18495928
[TBL] [Abstract][Full Text] [Related]
29. SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways.
Yuan H; Han Y; Wang X; Li N; Liu Q; Yin Y; Wang H; Pan L; Li L; Song K; Qiu T; Pan Q; Chen Q; Zhang G; Zang Y; Tan M; Zhang J; Li Q; Wang X; Jiang J; Qin J
Cancer Cell; 2020 Sep; 38(3):350-365.e7. PubMed ID: 32619406
[TBL] [Abstract][Full Text] [Related]
30. Use of histone methyltransferase inhibitors in cancer treatment: A systematic review.
Marzochi LL; Cuzziol CI; Nascimento Filho CHVD; Dos Santos JA; Castanhole-Nunes MMU; Pavarino ÉC; Guerra ENS; Goloni-Bertollo EM
Eur J Pharmacol; 2023 Apr; 944():175590. PubMed ID: 36775112
[TBL] [Abstract][Full Text] [Related]
31. ING2 recruits histone methyltransferase activity with methylation site specificity distinct from histone H3 lysines 4 and 9.
Goeman F; Otto K; Kyrylenko S; Schmidt O; Baniahmad A
Biochim Biophys Acta; 2008 Oct; 1783(10):1673-80. PubMed ID: 18513492
[TBL] [Abstract][Full Text] [Related]
32. Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer.
Patani N; Jiang WG; Newbold RF; Mokbel K
Anticancer Res; 2011 Dec; 31(12):4115-25. PubMed ID: 22199269
[TBL] [Abstract][Full Text] [Related]
33. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
34. Co-regulation of histone-modifying enzymes in cancer.
Islam AB; Richter WF; Jacobs LA; Lopez-Bigas N; Benevolenskaya EV
PLoS One; 2011; 6(8):e24023. PubMed ID: 21886846
[TBL] [Abstract][Full Text] [Related]
35. PRDM16 is associated with evasion of apoptosis by prostatic cancer cells according to RNA interference screening.
Zhu S; Xu Y; Song M; Chen G; Wang H; Zhao Y; Wang Z; Li F
Mol Med Rep; 2016 Oct; 14(4):3357-61. PubMed ID: 27511603
[TBL] [Abstract][Full Text] [Related]
36. Disturbing the histone code in leukemia: translocations and mutations affecting histone methyl transferases.
Chopra M; Bohlander SK
Cancer Genet; 2015 May; 208(5):192-205. PubMed ID: 25592767
[TBL] [Abstract][Full Text] [Related]
37. Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2.
Ougolkov AV; Bilim VN; Billadeau DD
Clin Cancer Res; 2008 Nov; 14(21):6790-6. PubMed ID: 18980972
[TBL] [Abstract][Full Text] [Related]
38. Histone trimethylation of the p53 gene by expression of a constitutively active prolactin receptor in prostate cancer cells.
Tan D; Tan S; Zhang J; Tang P; Huang J; Zhou W; Wu S
Chin J Physiol; 2013 Oct; 56(5):282-90. PubMed ID: 24032713
[TBL] [Abstract][Full Text] [Related]
39. Multifaceted Role of PRDM Proteins in Human Cancer.
Casamassimi A; Rienzo M; Di Zazzo E; Sorrentino A; Fiore D; Proto MC; Moncharmont B; Gazzerro P; Bifulco M; Abbondanza C
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290321
[TBL] [Abstract][Full Text] [Related]
40. Histone lysine methyltransferases as anti-cancer targets for drug discovery.
Liu Q; Wang MW
Acta Pharmacol Sin; 2016 Sep; 37(10):1273-1280. PubMed ID: 27397541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
